J2184 Meropenem (HCPCS) Reimbursement & Policy

HCPCS Level II code J2184 designates a 100 mg injection of meropenem (B. Braun) that is explicitly not therapeutically equivalent to J2185. This code identifies a parenteral broad-spectrum carbapenem antibiotic used in the treatment of serious bacterial infections and is relevant for hospital and acute-care billing. Nationally, accurate coding of injectable antimicrobials affects medication utilization tracking, hospital pharmacy billing, and payer coverage determinations.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context and service settings for J2184, along with benchmarks and coding considerations typically examined in reimbursement and utilization reviews. The publication outlines payer coverage patterns, common billing modifiers, and comparisons to related HCPCS codes where available.

The report also summarizes policy-relevant issues such as coding specificity for non-equivalent drug products, implications for formulary and prior authorization workflows, and points of attention for claim review. Data not available in the input is noted where applicable; the focus remains on national implications and practical coding context for clinicians, billers, and policy analysts.

Billing Code Overview

HCPCS Level II code J2184 describes an injection of meropenem (B. Braun) in a 100 mg strength that is specified as not therapeutically equivalent to J2185. The service represents administration of an intravenous antibiotic agent used for serious bacterial infections where meropenem is indicated.

Service type: Injectable antimicrobial administration
Typical site of service: Hospital inpatient and outpatient infusion settings, emergency department, and other acute care settings where parenteral antibiotic therapy is provided

Data not available in the input.

Clinical Context

A patient presents to an acute care setting (emergency department, observation unit, inpatient ward, or hospital outpatient infusion center) with a severe bacterial infection requiring broad-spectrum intravenous carbapenem therapy. Typical scenarios include suspected or confirmed complicated intra-abdominal infection, hospital-acquired pneumonia/ventilator-associated pneumonia, complicated urinary tract infection or pyelonephritis with systemic signs, or severe sepsis suspected to be caused by multidrug-resistant gram-negative organisms. The attending physician orders meropenem therapy using the specific branded formulation J2184 (meropenem, B. Braun, 100 mg vial) because the facility stocks that manufacturer and it is not considered therapeutically equivalent to other HCPCS J-codes (for example J2185).

Clinical workflow:

Patient evaluation and diagnosis by emergency or admitting team with documentation of infection source, severity, allergies, and renal function.
Order placed in the electronic health record for meropenem, specifying dose (weight-based or indication-based), frequency, and route (intravenous). Pharmacy verifies the order, selects the stocked J2184 product, compounds the dose (reconstitute and dilute), and prepares for intravenous administration.
Nurse documents medication administration, infusion route (IV push or infusion pump), start and stop times, lot number and vial quantity, and any immediate infusion-related reactions.
Subsequent monitoring includes clinical response, renal function, and microbiology culture/susceptibility results to guide de-escalation or continuation. Medication billing uses the HCPCS code J2184 with appropriate modifier(s) to reflect circumstances (e.g., for discarded drug, / when applicable for certified personnel, or billing condition modifiers).

Coding Specifications

Modifier	Description	When to Use
`00`	Default/No special modifier	When no additional billing modifier applies to the service.
`22`	Increased procedural services	Rarely used for drug administration; use only if documentation supports substantially greater service complexity related to drug preparation or administration beyond typical practice.
`23`	Unusual anesthesia	Not routinely applicable to IV antibiotic administration; use if unusual anesthesia was required for administration.
`52`	Reduced services	When the drug was ordered but only partially provided due to clinical change or intolerance.
`53`	Discontinued procedure	If administration was initiated but stopped for medical reasons before completion.
`62`	Two surgeons	Not applicable to drug billing; not typically used with injectable medications.
`78`	Return to operating room following surgery	Not applicable to medication administration billing.
`80`	Assistant surgeon	Not applicable to medication billing.
`82`	Assistant surgeon (when qualified resident unavailable)	Not applicable to medication billing.
`JW`	Amount of drug discarded/not administered	When some portion of the single-use vial is discarded and the payer allows billing only for administered amount; append `JW` per payer rules.
`JZ`	No wastage; full vial administered	When the entire vial was administered and no wastage occurred.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist-supply	Use when the service is furnished by an applicable non-physician practitioner per payer rules.
`QX`	CRNA services with medical direction by a physician	Not commonly used for IV antibiotic administration; include only if CRNA provided an associated service that is billable.
`QY`	Medical direction of more than four CRNAs by a physician	Not commonly used for standard infusion services.
`JW`	(Listed above)	Duplicate entry avoided; see above for use.
`FX`	Non-covered service when contractor deems not reasonable and necessary	Use only when payer-specific guidance requires this modifier for denied services.

Taxonomy Code	Specialty	Notes
`207Q00000X`	Infectious Disease Physician	Commonly directs antibiotic selection for complex or resistant infections.
`207L00000X`	Emergency Medicine Physician	Frequently initiates empiric broad-spectrum IV antibiotics in the ED.
`208000000X`	Hospitalist/Internal Medicine Physician	Manages inpatient continuation and monitoring of IV antibiotics.
`3336S0005X`	Clinical Pharmacist	Performs verification, compounding, dosing adjustments (especially renal dosing) and therapeutic drug management.
`364S00000X`	Registered Nurse	Administers IV infusion, documents administration and monitors for reactions.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`A41.9`	Sepsis, unspecified organism	Indicates systemic infection where broad-spectrum IV meropenem may be used empirically for severe sepsis.
`J15.9`	Unspecified bacterial pneumonia	Hospital-acquired or severe community-acquired pneumonia may require carbapenem therapy when resistant organisms are suspected.
`N39.0`	Urinary tract infection, site not specified	Complicated UTI or pyelonephritis with systemic signs may prompt IV meropenem.
`K35.80`	Acute appendicitis with generalized peritonitis	Complicated intra-abdominal infections often require broad-spectrum IV antimicrobials like meropenem.
`K65.0`	Acute peritonitis	Intra-abdominal sepsis indications where meropenem is appropriate for empiric coverage.
`B96.5`	Escherichia coli as the cause of diseases classified elsewhere	Identified resistant gram-negative pathogens may justify meropenem therapy.
`A49.9`	Bacterial infection, unspecified	Empiric broad-spectrum therapy may be used pending culture results.
`T88.7XXA`	Unspecified adverse effect of drug, initial encounter	Relevant for documenting and billing if an adverse reaction to meropenem necessitates additional care.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when meropenem is administered as an infusion and the initial infusion time is billable per payer rules.
`96366`	Intravenous infusion; each additional hour	Used for prolonged infusions beyond the initial hour if clinically indicated and billable.
`96374`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular	May be used if a single bolus injection route (IM) were applicable; not typical for meropenem but listed for related workflows.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Generally not used for meropenem (IV preferred) but included for settings where an alternative route is used.
`96377`	Intravenous push, single or initial substance/drug	Used when meropenem is administered via IV push and meets payer criteria for coding.
`36415`	Collection of venous blood by venipuncture	Often performed for baseline labs, cultures, and monitoring related to initiating IV meropenem therapy.

OpenPayer

Summary & Overview

HCPCS J2184: Meropenem Injection, 100 mg